SPY304.32+1.35 0.45%
DIA254.29-0.06 -0.02%
IXIC9,489.87+120.88 1.29%

AcelRx Pharmaceuticals Q1 EPS $(0.200) Misses $(0.170) Estimate, Sales $386.000K Up From $265.000K YoY

AcelRx Pharmaceuticals (NASDAQ:ACRX) reported quarterly losses of $(0.200) per share which missed the analyst consensus estimate of $(0.170) by 17.65 percent. This is a 17.65 percent decrease over losses of $(0.170) per

Benzinga · 05/11/2020 20:16

AcelRx Pharmaceuticals (NASDAQ:ACRX) reported quarterly losses of $(0.200) per share which missed the analyst consensus estimate of $(0.170) by 17.65 percent. This is a 17.65 percent decrease over losses of $(0.170) per share from the same period last year. The company reported $386.000 thousand in sales this quarter. This is a 45.66 percent increase over sales of $265.000 thousand the same period last year.